Licensed Practical Nurse in Cherokee, NC Accepting Medicare
6 Licensed Practical Nurse nurses found. Showing 1 - 6
 Karen Marie Taylor, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 73 Kaiser Wilnoty, Cherokee, NC 28719 Phone: 828-554-6250 Fax: 828-497-3829 |
Ms. Adrianne Davis, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 448 Sequoyah Trl, Cherokee, NC 28719 Phone: 828-554-0523 |
Janice Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 876 Acquoni Rd, Cherokee, NC 28719 Phone: 828-497-9163 Fax: 828-497-5343 |
Rhonda C Long, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 64 John Crow Hill, Cherokee, NC 29719 Phone: 828-497-9163 Fax: 828-497-5343 |
Darlene Walker, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 806 Acquoni Rd, Suite 100, Cherokee, NC 28719 Phone: 828-497-1991 Fax: 828-497-8194 |
Mary Jo Taylor, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 64 John Crow Hill, Cherokee, NC 28719 Phone: 828-497-9163 Fax: 828-497-5343 |
News Archive
Risk for childhood cancer moderately increased among adolescents with major birth defects
A multistate study led by researchers at the University of Utah has revealed that the risk for childhood cancer is moderately increased among children and young adolescents with certain types of major birth defects.
CytRx granted patent for molecular chaperone amplifier drug candidate
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
Genomic analysis leads to more effective diagnostic tests, treatment options for prostate cancer: Study
A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. "Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients into clinically meaningful subgroups that improve treatment decisions," said senior study author Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program at MSKCC and a HHMI investigator. "This first -ever database of its type brings us one step closer to achieving that goal in prostate cancer."
Entomologist to study how immune system responds to rickettsial infection
Summer for most people means time spent outdoors, which could also mean increased exposure to bugs and, possibly, arthropod-borne diseases, such as "rickettsial diseases" - infectious diseases spread by bacteria, which, generally, are transmitted by lice, fleas, ticks and mites.
› Verified 1 days ago
Registered Nurse
Physician Assistant
Nurse Practitioner
Licensed Practical Nurse